{
    "nctId": "NCT00182520",
    "title": "A Study of Topiramate Augmentation in Serotonin Reuptake Inhibitor (SRI) -Refractory Obsessive Compulsive Disorder",
    "symPyJSON": {
        "type": "and",
        "operands": [
            {
                "type": "variable",
                "value": "Outpatient with primary DSM- IV OCD"
            },
            {
                "type": "variable",
                "value": "Completion of a 14-week open label trial of one the following SRI's: fluoxetine 80 mg/day, paroxetine 60 mg/day, fluvoxamine 300 mg/day, clomipramine 250 mg/day, sertraline 200 mg/day, citalopram 60 mg/day, escitalopram 30 mg/day and demonstrating a non or partial responses to SRI treatment (CGI-I of 3 or 4, Y-BOCS reduction of < 35%)"
            },
            {
                "type": "variable",
                "value": "Stable (8 wks or longer) concurrent medications including benzodiazepines, sedative hypnotics, antipsychotics, and antidepressants."
            },
            {
                "type": "variable",
                "value": "Must have minimum age of 18 Years"
            },
            {
                "type": "variable",
                "value": "Must have maximum age of 65 Years"
            },
            {
                "type": "not",
                "operands": [
                    {
                        "type": "or",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "Any other primary DSM-IV diagnosis"
                            },
                            {
                                "type": "variable",
                                "value": "DSM-IV criteria for body dysmorphic disorder"
                            },
                            {
                                "type": "variable",
                                "value": "DSM-IV criteria for bipolar affective disorder"
                            },
                            {
                                "type": "variable",
                                "value": "DSM-IV criteria for schizophrenia"
                            },
                            {
                                "type": "variable",
                                "value": "DSM-IV criteria for psychotic disorder"
                            },
                            {
                                "type": "variable",
                                "value": "current alcohol/substance abuse"
                            },
                            {
                                "type": "variable",
                                "value": "A previous adequate trial of topiramate"
                            },
                            {
                                "type": "variable",
                                "value": "Comorbid major depressive disorder diagnosis which predates OCD diagnosis"
                            },
                            {
                                "type": "variable",
                                "value": "Cognitive behavioural therapy or additional psychotherapy in past four months"
                            },
                            {
                                "type": "variable",
                                "value": "Allergy or hypersensitivity to topiramate"
                            },
                            {
                                "type": "variable",
                                "value": "BMI < 20"
                            },
                            {
                                "type": "variable",
                                "value": "History of kidney stones"
                            }
                        ]
                    }
                ]
            }
        ]
    },
    "symPyExpression": "And(Symbol(\"Completion of a 14-week open label trial of one the following SRI's: fluoxetine 80 mg/day, paroxetine 60 mg/day, fluvoxamine 300 mg/day, clomipramine 250 mg/day, sertraline 200 mg/day, citalopram 60 mg/day, escitalopram 30 mg/day and demonstrating a non or partial responses to SRI treatment (CGI-I of 3 or 4, Y-BOCS reduction of < 35%)\"), Symbol('Must have maximum age of 65 Years'), Symbol('Must have minimum age of 18 Years'), Symbol('Outpatient with primary DSM- IV OCD'), Symbol('Stable (8 wks or longer) concurrent medications including benzodiazepines, sedative hypnotics, antipsychotics, and antidepressants.'), Not(Or(Symbol('A previous adequate trial of topiramate'), Symbol('Allergy or hypersensitivity to topiramate'), Symbol('Any other primary DSM-IV diagnosis'), Symbol('BMI < 20'), Symbol('Cognitive behavioural therapy or additional psychotherapy in past four months'), Symbol('Comorbid major depressive disorder diagnosis which predates OCD diagnosis'), Symbol('DSM-IV criteria for bipolar affective disorder'), Symbol('DSM-IV criteria for body dysmorphic disorder'), Symbol('DSM-IV criteria for psychotic disorder'), Symbol('DSM-IV criteria for schizophrenia'), Symbol('History of kidney stones'), Symbol('current alcohol/substance abuse'))))"
}